A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS.

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Abstract Text:

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Publishing Authors By Initials

For similar polycyclic compounds: steroids research abstracts see: polycyclic compounds: steroids research

PUBMED ID PMID:

MEDLINE DATE:

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the American Geriatrics Society

VOLUME: 11

Page Numbers: 979-82

Journal Abbreviation: J Am Geriatr Soc

ISSN: 0002-8614

DAY: 10

MONTH: Oct

YEAR: 1963

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503062

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Keywords Mesh Terms:

KEYWORDS: Steroids

MESH TERMS:

Chemical & Substance for Abstract: A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS. Information

Substance Name: Steroids

Registry Number: 0

Grant and Affiliation Information for A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Am Geriatr Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A STEROIDAL PYRAZOLE AS AN ANABOLIC AGENT IN THE TREATMENT OF GERIATRIC MENTAL PATIENTS Related Publications

• A method for isolating living polymorphonuclear leukocytes from peripheral blood.
• An early regime for severe finger injuries.
• Anomalous channel between aorta and right ventricle; report of a case.
• Association between maternal exposure to ambient air pollutants during pregnancy and fetal growth restriction.
• BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors.
• Cystic emphysema of the lungs.
• Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.
• Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure.
• Does androgen suppression plus radiation therapy lead to changes in penile length in prostate cancer patients?
• Effectiveness of repellents applied to clothing for protection against salt-marsh mosquitoes.
• Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.
• Erythropoietin receptor expression in the human urogenital tract: immunolocalization in the prostate, neurovascular bundle and penis.
• Ethical considerations in the use of DNA for the diagnosis of diseases.
• FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms.
• Large-scale purification and crystallization of adenovirus hexon.
• MRC trials in acute myeloblastic luekemia: Where have we got to?
• Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU.
• Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health.
• NADPH oxidase: recent evidence for its role in erectile dysfunction.
• Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular disease.
• Periodically poled BaMgF(4) for ultraviolet frequency generation.
• Refractivity of nitrogen gas in the vacuum ultraviolet.
• Review of meningioma histopathology.
• Rights and the reality of healthcare charging in the United Kingdom.
• Roaches; how to identify and principles of control.
• Sapropterin dihydrochloride (Kuvan/phenoptin), an orally active synthetic form of BH4 for the treatment of phenylketonuria.
• The perforated appendix.
• Unusual strangulated hernias in infants.
• Validation and feasibility of intraoperative three-dimensional transesophageal echocardiographic cardiac output.
• Vulnerable elders: when it is no longer safe to live alone.